Laurus plant gets 3 observations

Hyderabad: Laurus Labs Limited, on Thursday said that it has completed the USFDA, Pre-Approval Inspection (PAI) for an API manufactured at its Units 1&3, located at J N Pharma City, Parawada, Visakhapatnam, Andhra Pradesh, with three observations, which are procedural in nature.

No data integrity issues were observed in the inspection. The inspection was carried out from November 18-21, said the company.

"We are thriving on growth opportunities in formulation manufacturing to service all leading markets of North America, Europe and Low Middle Income Countries (LMIC) and are driving growth opportunities in Contract Development and Manufacturing through our Synthesis business," added the company